Crispr Therapeutics Ag (CRSP)

Oct 01, 2026

CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 01, 2026

Sep 30, 2026

CRISPR Therapeutics AG (CRSP) stock price, news, quote and history - uk.finance.yahoo.com

Sep 30, 2026

Sep 30, 2026

Anthropic Just Made a CRISPR-Like Discovery. What It Actually Means for CRSP Stock Investors. - Yahoo Finance

Sep 30, 2026

Sep 30, 2026

CRISPR Therapeutics AG (CRSP) Stock forecasts - Yahoo Finance Singapore

Sep 30, 2026

Sep 29, 2026

Total common shares outstanding of CRISPR Therapeutics AG – HAN:1CG - TradingView

Sep 29, 2026

Sep 29, 2026

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Sep 29, 2026

Sep 29, 2026

CRISPR Therapeutics Has 2 Key Catalysts Coming by the End of 2026. Is the Market Underestimating Them? - The Motley Fool

Sep 29, 2026

Sep 28, 2026

CRISPR Therapeutics stock price target reaffirmed at $80 by Citizens - Investing.com

Sep 28, 2026

Sep 27, 2026

One CRISPR treatment cut “bad” cholesterol in half for a full year - ScienceDaily

Sep 27, 2026

Sep 27, 2026

Form 144 CRISPR THERAPEUTICS AG For: 27 September By Investing.com - Investing.com Nigeria

Sep 27, 2026

Sep 26, 2026

Crispr Therapeutics AG (CRSP) Stock Price Today: $54.23 - Pluang

Sep 26, 2026

Sep 26, 2026

CRSP Stock Climbs After-Hours As CRISPR Maps Busy Second-Half Pipeline After Upbeat Q2 - Stocktwits

Sep 26, 2026

Sep 25, 2026

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Sep 25, 2026

Sep 25, 2026

CRISPR Therapeutics stock analysis: pipeline catalysts vs. financial reality - Investing.com

Sep 25, 2026

Sep 24, 2026

Form 4 CRISPR Therapeutics AG For: 24 September By Investing.com - Investing.com Canada

Sep 24, 2026

Sep 24, 2026

Form 4 CRISPR Therapeutics AG For: 24 September - Investing.com India

Sep 24, 2026

Sep 24, 2026

CRISPR Therapeutics' General Counsel James R. Kasinger Sells 10,400 Shares Following Option Exercise - Kalkine Media

Sep 24, 2026

Sep 24, 2026

CRISPR Therapeutics (NASDAQ:CRSP) General Counsel James Kasinger Sells 10,400 Shares of Company Stock - MarketBeat

Sep 24, 2026

Sep 24, 2026

CRISPR Therapeutics (CRSP) counsel exercised options and sold 10,400 shares under a trading plan. - Stock Titan

Sep 24, 2026

Sep 24, 2026

CRISPR Therapeutics' Casgevy sales jump 78% in Q2, boosting long-term buy case despite AI gene editing risks - Pluang

Sep 24, 2026

Sep 24, 2026

Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing (CRSP) - Seeking Alpha

Sep 24, 2026

Sep 24, 2026

CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Sep 24, 2026

Sep 23, 2026

CRISPR Therapeutics (CRSP) Shares Dip Amid Anthropic AI Enzyme D - GuruFocus

Sep 23, 2026

Sep 23, 2026

Gene editing stocks fall after Anthropic’s CRISPR-like discovery - Seeking Alpha

Sep 23, 2026

Sep 23, 2026

CRISPR Therapeutics stock trades below targets despite approved gene therapy; analyst sees 85% upside potential. - Pluang

Sep 23, 2026

Sep 23, 2026

CRISPR Therapeutics AG (CRSP) Options ChainYahoo Finance - Yahoo! Finance Canada

Sep 23, 2026

Sep 23, 2026

Autologous Hematopoietic Stem Cell Gene Therapy Market - GlobeNewswire

Sep 23, 2026

Sep 23, 2026

Autologous Hematopoietic Stem Cell Gene Therapy Market Global Report 2026: A $13.44 Billion Market by 2030 as Novartis, Vertex, CRISPR Therapeutics and Orchard Therapeutics Accelerate the Gene-Editing Race - uk.finance.yahoo.com

Sep 23, 2026

Sep 23, 2026

What Put the CRISPR Therapeutics (CRSP) Story on the Radar? - Kalkine Media

Sep 23, 2026

Sep 22, 2026

CRISPR Therapeutics AG (CRSP) Stock Moves 1.20%: What You Should Know - Yahoo Finance

Sep 22, 2026

Sep 22, 2026

Insider plans $626K CRISPR Therapeutics (NASDAQ: CRSP) stock sale - Stock Titan

Sep 22, 2026

Sep 22, 2026

symbol__ Stock Quote Price and Forecast - CNN

Sep 22, 2026

Sep 21, 2026

Ali Behbahani Sells 13,679 Shares of CRISPR Therapeutics (NASDAQ:CRSP) Stock - MarketBeat

Sep 21, 2026

Sep 21, 2026

CRISPR Therapeutics (CRSP) director exercises options, then sells 13,679 shares around $57 - Stock Titan

Sep 21, 2026

Sep 21, 2026

Director at CRISPR Therapeutics (CRSP) gets stock in no-cash fund distribution - Stock Titan

Sep 21, 2026

Sep 20, 2026

Why CRISPR Therapeutics (CRSP) Is Back In The Spotlight - simplywall.st

Sep 20, 2026

Sep 20, 2026

New Treatment Cuts “Bad” Cholesterol in Half for a Full Year - SciTechDaily

Sep 20, 2026

Sep 20, 2026

CRISPR Therapeutics stock edges lower as investors digest latest pipeline and earnings figures - AD HOC NEWS

Sep 20, 2026

Sep 20, 2026

3 Reasons CRISPR Therapeutics Stock Is Still a Buy After a Rocky 2026 - The Motley Fool

Sep 20, 2026

Sep 18, 2026

Crispr Therapeutics' Diverse Gene Editing Portfolio Supports Positive Long-Term Outlook - Morningstar

Sep 18, 2026

Sep 18, 2026

CRISPR Therapeutics AG (CRSP) Stock Forecasts - Yahoo Finance

Sep 18, 2026

Sep 18, 2026

Can Intellia's Pipeline Progress Create Long-Term Value Amid Rivalry? - TradingView

Sep 18, 2026

Sep 18, 2026

Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? - The Motley Fool

Sep 18, 2026

Sep 17, 2026

CRISPR Therapeutics (NASDAQ:CRSP): What's Behind Its Stock Surge? - Kalkine Media

Sep 17, 2026

Sep 17, 2026

Director at CRISPR Therapeutics (NASDAQ: CRSP) files notice for six-figure stock sale - Stock Titan

Sep 17, 2026

Sep 17, 2026

CRISPR Therapeutics (NASDAQ:CRSP) Shares Up 11.6%What's Next? - MarketBeat

Sep 17, 2026

Sep 17, 2026

CRISPR Therapeutics Surges 11.39% as CRSP Stock Breaks Above $58RSI Oversold Picks - careplusvn.com

Sep 17, 2026

Sep 17, 2026

Wall Street Analysts Think CRISPR Therapeutics (CRSP) Is a Good Investment: Is It? - Yahoo Finance

Sep 17, 2026